These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13183549)

  • 1. [Isolation of leishmaniae in the viscera and the skin of a fox in the kala-azar endemic zone in Sobral, Ceara].
    DEANE LM; DEANE MP
    Hospital (Rio J); 1954 Apr; 45(4):419-21. PubMed ID: 13183549
    [No Abstract]   [Full Text] [Related]  

  • 2. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
    Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
    Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of visceral leishmaniasis associated with the behaviors of the people in rural areas.
    Shah H
    JNMA J Nepal Med Assoc; 2005; 44(160):116-20. PubMed ID: 16751812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual presentation of post-kala-azar dermal leishmaniasis.
    Ramesh V; Kumar J; Salotra P
    Trop Doct; 2007 Jul; 37(3):172-3. PubMed ID: 17716510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-Kala-Azar-dermal-leishmaniasis: an unusual presentation from Uttarachal (a non-endemic hilly region of India).
    Joshi A; Gulati A; Pathak VP; Bansal R
    Indian J Dermatol Venereol Leprol; 2002; 68(3):171-3. PubMed ID: 17656928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report.
    Toran KC; Sah SP; Joshi A; Rani S
    Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phlebotomus species in the Central Serbia, vectors of kala-azar].
    SIMIC C; IGNJATOVIC B
    Glas Belgrad Hig Inst NR Srb; 1954; 3(1-2):24-7. PubMed ID: 14353334
    [No Abstract]   [Full Text] [Related]  

  • 8. [Problem of kala-azar in Bulgaria].
    IONKOV I; STANCHEV A; ATAMASOV E
    Suvr Med (Sofiia); 1954; 5(3):96-103. PubMed ID: 13205454
    [No Abstract]   [Full Text] [Related]  

  • 9. [Endemic kala azar in Jacobina (State of Bahia)].
    PESSOA SB; DA SILVA LH; FIGUEIREDO J
    Rev Bras Malariol Doencas Trop; 1955 Apr; 7(2):245-50. PubMed ID: 13310894
    [No Abstract]   [Full Text] [Related]  

  • 10. Present situation of vector-control management in Bangladesh: a wake up call.
    Mondal D; Alam MS; Karim Z; Haque R; Boelaert M; Kroeger A
    Health Policy; 2008 Sep; 87(3):369-76. PubMed ID: 18342389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Feline leishmaniasis: what's the epidemiological role of the cat?].
    Mancianti F
    Parassitologia; 2004 Jun; 46(1-2):203-6. PubMed ID: 15305717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post kala azar dermal leishmaniasis in Sudan.
    Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
    East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kala azar in the valley of the Jaguaribe river, Ceara, 1955].
    DE ALENCAR JE; HOLANDA D; CAVALCANTE JD
    Rev Bras Malariol Doencas Trop; 1956 Jan; 8(1):33-47. PubMed ID: 13494826
    [No Abstract]   [Full Text] [Related]  

  • 14. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?
    Mendiratta V; Chander R
    Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001
    [No Abstract]   [Full Text] [Related]  

  • 15. Kala-azar (visceral Leishmaniasis) from Khotang.
    Joshi S; Bajracharya BL; Baral MR
    Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
    Karki P; Koirala S; Parija SC; Sethi M; Das ML
    Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for Indian kala-azar.
    Ranjan A; Sur D; Singh VP; Siddique NA; Manna B; Lal CS; Sinha PK; Kishore K; Bhattacharya SK
    Am J Trop Med Hyg; 2005 Jul; 73(1):74-8. PubMed ID: 16014837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Kala-Azar in Irak].
    KIRCHMAIR H
    Z Tropenmed Parasitol; 1955 Apr; 6(1):122-4. PubMed ID: 14387078
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of rK39 for diagnosis of post kala-azar dermal leishmaniasis in Nepal.
    Das ML; Deb M; Karki BM; Sarif M; Khanal B; Bhattacharya SK; Agrawal S; Koirala S
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):619-25. PubMed ID: 17882997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
    Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
    J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.